VASCULOPATHY

Clinical trials for VASCULOPATHY explained in plain language.

Never miss a new study

Get alerted when new VASCULOPATHY trials appear

Sign up with your email to follow new studies for VASCULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Completed 1

Heart transplant patients get new weapon against hidden artery damage

Disease control Completed

This study tested the drug alirocumab in 114 heart transplant recipients to see if it could slow or prevent a common complication called cardiac allograft vasculopathy (CAV), where the heart's blood vessels narrow. Participants received the drug soon after transplant, and researc…

Matched conditions: VASCULOPATHY

Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control

Last updated May 27, 2026 23:06 UTC

VASCULOPATHY

Get alerted when new VASCULOPATHY trials appear

Heart transplant patients get new weapon against hidden artery damage